Morgan Stanley reaffirmed its Overweight rating on Rocket Lab (RKLB) and kept its price target unchanged at $105, while raising its most optimistic bull-case target to $293 from $185.
According to Odaily, Morgan Stanley analysts said Rocket Lab’s acquisition of Iridium would expand the company’s potential market and reposition it as a vertically integrated space platform.
The analysts added that while SpaceX has significant scale and cost advantages over Rocket Lab, Rocket Lab is moving toward a similar model.
STOCKS | Morgan Stanley Reaffirms Overweight Rating on Rocket Lab and Raises Bull-Case Target to $293
2026-07-08 12:14:30
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
Hungary Considered 25- and 50-Basis-Point Rate Cuts on June 23
